Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNICANCER
Bristol-Myers Squibb
Brigham and Women's Hospital
Hoffmann-La Roche
M.D. Anderson Cancer Center
Melanoma Institute Australia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Melanoma Institute Australia
Yale University
Grupo Español Multidisciplinar de Melanoma
SWOG Cancer Research Network
Stanford University
Yale University
Grupo Español Multidisciplinar de Melanoma
Centre hospitalier de l'Université de Montréal (CHUM)
Ohio State University Comprehensive Cancer Center
University Medical Center Groningen
Memorial Sloan Kettering Cancer Center
Technische Universität Dresden
Hoffmann-La Roche
Herlev Hospital
Eastern Cooperative Oncology Group
Pfizer
Grupo Español Multidisciplinar de Melanoma
Duke University
Canadian Cancer Trials Group
University of Michigan Rogel Cancer Center
Yale University
University Hospital Tuebingen
Eli Lilly and Company
DEKK-TEC, Inc.
Center Eugene Marquis
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Novartis
GlaxoSmithKline
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University Hospital, Lille
Memorial Sloan Kettering Cancer Center
Pharmacyclics LLC.
GlaxoSmithKline
National Cancer Institute (NCI)
SWOG Cancer Research Network
National Cancer Institute (NCI)